Photo of Gregory S. Calip

Gregory S. Calip

Affiliate, Center for Pharmacoepidemiology and Pharmacoeconomic Research
Director, UIC-AbbVie Fellowship in Pharmacovigilance and Patient Safety
Member, Cancer Prevention and Control Research Program
Associate Professor, Pharmacy Systems, Outcomes and Policy

Related Sites:

Teaching and Supervision

Independent Study (PSOP 596), 6/14/2021 – 8/6/2021
Ph.D. Thesis Research (PSOP 599), 1/11/2021 – 4/30/2021
PSOP Project (PSOP 597), 1/11/2021 – 4/30/2021
Projects Pharm Syst Outcomes (PSOP 390), 1/11/2021 – 4/30/2021
Independent Study (PSOP 596), 1/11/2021 – 4/30/2021
Epidemiology/Biostatistics (PHAR 439), 1/11/2021 – 2/12/2021
Epidemiology/Biostatistics (PHAR 439), 1/11/2021 – 2/12/2021
Spec Topic Pharm Syst Outcomes (PSOP 594), 8/24/2020 – 12/4/2020
Ph.D. Thesis Research (PSOP 599), 8/24/2020 – 12/4/2020

Selected Grants

3/3: The Chicago Cancer Health Equity Collaborative (ChicagoCHEC), National Institutes of Health (National Cancer Institute)., 9/22/2020 - 8/31/2025, Obligated Amount: $1366169; Anticipated Amount: $6834852

Increasing the cure fraction in myeloma- a novel strategy to personalize melphalan dosing and overcome DNA repair-mediated resistance, UIC College of Pharmacy., 8/1/2020 - 7/31/2021, Obligated Amount: $25000; No Anticipated Amount Set

Incoming MTA - Trends of opioid prescribing by dentits, National Institutes of Health (National Cancer Institute)., 7/29/2020 - 7/28/2023, No Obligated Amount Set; No Anticipated Amount Set

Novel gut microbial biomarkers and the adverse metabolic effects of atypical antipsychotics, National Institutes of Health., 4/2020 - 3/2022, No Obligated Amount Set; No Anticipated Amount Set

Pilot Study to Develop and Test a Multiplex Assay for CYP450 Phenotyping in Multiple Myeloma Patients Receiving Bortezomib, Hematology Oncology Pharmacy Association (HOPA)., 3/1/2020 - 2/28/2022, Obligated Amount: $85283; Anticipated Amount: $85283

Prevention of Venous Thromboembolism in Multiple Myeloma: The Thromboprophylaxis Multi-Cohort Study, National Institutes of Health., 12/2019 - 11/2023, No Obligated Amount Set; No Anticipated Amount Set

UIC Subaward for Dental prescribing of antibiotics and opioids: high use in the absence of evidence, University of Pittsburgh., 11/1/2019 - 7/31/2021, Obligated Amount: $360368; Anticipated Amount: $360368

Surveillance, Epidemiology, and End Results based Real-World Evidence in EArLy Breast Cancer (SEER-REAL-BC) Studies: Patient Characteristics, Treatment Patterns, and Outcomes in Patients with HR+/HER2- early-stage breast cancer, Pfizer., 8/19/2019 - 8/19/2021, No Obligated Amount Set; No Anticipated Amount Set

Pfizer outcomes research agreement, Pfizer Inc., 8/19/2019 - 8/19/2021, Obligated Amount: $396464; Anticipated Amount: $396464

Selected Publications

Zhou, J, Cueto, J, Ko, NY, Hoskins, KF, Nabulsi, NA, Asfaw, AA, Hubbard, CC, Mitra, D, Calip, GS, Law, EH. (2021). Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race. Breast, 59, 367-375. doi:10.1016/j.breast.2021.08.005.

Hoskins, KF, Calip, GS. (2021). Racial/Ethnic Differences in the 21-Gene Recurrence Score Assay among Women with Breast Cancer – Reply. JAMA Oncology, 7, (8), 1248-1249. doi:10.1001/jamaoncol.2021.1959.

Calip, GS, Miksad, RA, Sarkar, S. (2021). Time-Related Biases in Nonrandomized COVID-19-Era Studies Using Real-world Data. JAMA Oncology, 7, (8), 1175-1177. doi:10.1001/jamaoncol.2021.1715.

Guadamuz, JS, Durazo-Arvizu, RA, Daviglus, ML, Calip, GS, Nutescu, EA, Qato, DM. (2021). Statin nonadherence in Latino and noncitizen neighborhoods in New York City, Los Angeles, and Chicago, 2012-2016. Journal of the American Pharmacists Association, 61, (4), e263-e278. doi:10.1016/j.japh.2021.01.032.

Calip, GS, Yerram, P, Ascha, MS. (2021). Nonrandomized Comparison of Adverse Events following Facility- And Home-Infused Biologics Using Real-World Data. JAMA Network Open, 4, (6). doi:10.1001/jamanetworkopen.2021.11156.

Takvorian, Samuel U, Parikh, Ravi Bharat, Vader, Daniel, Wileyto, E Paul, Clark, Amy Sanders, Lee, Daniel J, Goyal, Gaurav, Rocque, Gabrielle Betty, Dotan, Efrat, Geynisman, Daniel M, Phull, Pooja, Spiess, Philippe E, Kim, Roger, Davidoff, Amy J, Gross, Cary Philip, Miksad, Rebecca A, Calip, Gregory Sampang, Shulman, Lawrence N, Mamtani, Ronac, Hubbard, Rebecca A. (2021). Impact of COVID-19 pandemic on time to treatment initiation for patients with advanced cancer.. Journal of Clinical Oncology, 39, (15_suppl), 1528-1528. doi:10.1200/jco.2021.39.15_suppl.1528.

Wang, Xiaoliang, Ascha, Mustafa, Green, Tammy, Lewin, Heather G, Showalter, Timothy N, Goldstein, Lori J, Calip, Gregory Sampang, Whitaker, Kristen Danielle. (2021). Racial disparities in second-line (2L) treatment and overall survival among patients (pts) with hormone receptor positive HER2 negative (HR+HER2-) metastatic breast cancer (mBC) treated in routine practice.. Journal of Clinical Oncology, 39, (15_suppl), 6541-6541. doi:10.1200/jco.2021.39.15_suppl.6541.

Hoskins, Kent, Calip, Gregory Sampang, Danciu, Oana Cristina, Rauscher, Garth H. (2021). What accounts for the racial disparity in survival from estrogen receptor-positive, axillary node-negative breast cancer in the United States? An analysis of the SEER-Oncotype database.. Journal of Clinical Oncology, 39, (15_suppl), 6534-6534. doi:10.1200/jco.2021.39.15_suppl.6534.

Hanson, Kent, Hoskins, Kent, Ko, Naomi Yu, Calip, Gregory Sampang. (2021). Multi-gene prognostic assays and age-related differences in prediction of pathologic complete response to neoadjuvant chemotherapy and survival in breast cancer.. Journal of Clinical Oncology, 39, (15_suppl), 591-591. doi:10.1200/jco.2021.39.15_suppl.591.

Professional Leadership

NIH Center for Scientific Review, 9/7/2020 - 9/9/2020


PharmD, University of Illinois at Chicago, United States, 2008
MPH, New York University, United States, 2010
PhD, University of Washington, United States, 2014

Postgraduate Training:
NCI Cancer Prevention Training Grant in Nutrition, Exercise and Genetics, Fred Hutchinson Cancer Research Center, United States, 2014

Licensures and Certifications

Registered Pharmacist, Washington State, Date Not Set - Present
Registered Pharmacist, New York State, Date Not Set - Present
Registered Pharmacist, Illinois State, Date Not Set - Present
Immunization Provider, APhA, Date Not Set - Present
CPR-AED Training, American Red Cross, Date Not Set - Present
Pharmacy Provider, NPI, Date Not Set - Present